Outcomes After Descemet Stripping Automated Endothelial Keratoplasty in XXXX With @entity726 .

@entity1 @entity2840 @entity409 @entity726 @entity177 @entity3279
PURPOSE: To evaluate outcomes after Descemet stripping automated endothelial keratoplasty in eyes with @entity726 drainage devices. METHODS: This is a retrospective review of 24 cases performed by a single surgeon (S.B.H.) on 20 eyes. Data were gathered on demographics, ocular history, surgical details, and postoperative outcomes. Outcome measures included @entity177 , secondary graft failure, endothelial cell density (ECD), @entity2840 ( @entity2840 ), intraocular pressure, and visual acuity. RESULTS: With a mean follow-up of 30.3    19.6 months, there was no occurrence of @entity177 , and the rate of secondary graft failure was 29%. Survival rates at 1, 2, and 3 years, respectively, were 87% [95% confidence interval (CI): 65%-96%], 80% (95% CI: 55%-92%), and 70% (95% CI: 39%-88%). Compared with ECD of the donor lenticule, endothelial cell loss was 49    16% (n = 21) at postoperative month 3, 59    16% (n = 20) at month 6, 61    20% (n = 16) at month 12, and stabilized at 75    17% (n = 9) by month 18. Compared with @entity2840 during the visit before surgery, @entity2840 decreased to 83    18% (n = 18) at postoperative month 3 and gradually increased to 95    11% (n = 6) at month 24. There were 4 (17%) cases of intraocular pressure elevation above 25 mm Hg. Improved visual acuity occurred in 71% of @entity1 . CONCLUSIONS: Descemet stripping automated endothelial keratoplasty in eyes with @entity3279 secondary to @entity409 in the presence of a previous @entity726 drainage device is a successful procedure. However, intermediate term endothelial cell loss is significant, as is the graft failure rate.
